Silk! Just the word invokes intrigue and fantasies of lavish mounds of richly hued fabrics. The journey of metamorphosis from caterpillar to silken luxury is miraculous. Textile artist Karen Selk delves into the amazing world of wild silk and the Indigenous people of India who raise the wild silkworms. You'll be drawn into the captivating world of a unique living culture that has been engaged in a sustainable industry for generations. Photos and anecdotes captured from weavers, spinners, and silkworm farmers transport you into their homes and villages to get an up-close look at the intimate connection to the skill, dedication, and specialized tools and techniques the artisans use to transform cocoons into yarn and luxurious fabrics. This little-known industry not only provides us with resplendent cloth but improves our environment and provides a sustainable income, allowing families and communities to stay together while preserving a way of life.

This work provides a history of the International Ladies' Garment Workers' Union. Topics covered include: the union's influence on political legislation and global economy; the story of the East European immigrants at the turn of the 20th century; and the union's spirit of social reform.

This work provides a history of the International Ladies' Garment Workers' Union. Topics covered include: the union's influence on political legislation and global economy; the story of the East European immigrants at the turn of the 20th century; and the union's spirit of social reform.

This work covers in depth the new patterns of manufacturing and technology transfer that are emerging as Japanese companies seek to harness Asia's technological resources, and to utilise them to compete both regionally and globally.

The author presents an argument for a system of social insurance that replaces welfare with a Guaranteed Adequate Income. The book reviews public assistance programmes, and evaluates other plans that have been proposed.

The author presents an argument for a system of social insurance that replaces welfare with a Guaranteed Adequate Income. The book reviews public assistance programmes, and evaluates other plans that have been proposed.

Updated and expanded! The authoritative guide to conceiving and launching your own home-based food business - from idea to recipe to final product. Follow your dream to launch a food business from your home and join the booming movement of food entrepreneurs. Fully updated and expanded, Homemade for Sale, Second Edition is the authoritative guide to launching a successful food enterprise from your kitchen. It covers everything you need to get cooking for your customers, providing a clear road map to go from ideas and recipes to owning a food business. Contents includes: Product development and testing Understanding state cottage food and food freedom laws and advocacy Independently tested recipes for non-hazardous food products, including frostings Marketing and developing your niche Step-by-step guides for packaging, labeling, and creating displays Structuring and running your business while planning for the future Bookkeeping and financial management Managing liability, risk, and government regulations Avoiding burnout through self-care and time management Profiles of successful food entrepreneurs. More people than ever are demanding real food made with real ingredients by real people, and you have the freedom to earn by starting a food business from home. No capital needed, just good recipes and enthusiasm, plus enough business know-how found in the pages of Homemade for Sale to be a success. Everything else is probably already in your kitchen. Best of all, you can start right now!

During the last five years, clinical research and development costs have risen exponentially without a proportionate increase in the number of new medications. While patient recruitment for clinical studies is only one component in the development of a new medicine or treatment, it is one of the most significant bottlenecks in the overall drug development process. Now it is imperative that industry leaders see beyond reactive measures and recognize that advancing their approach to patient recruitment is absolutely essential to advancing medicine and continuing the stability of their corporate brand across the globe. Reinventing Patient Recruitment: Revolutionary Ideas for Clinical Trial Success is a definitive guide to planning, implementing and evaluating recruitment strategies and campaigns globally. The combined experience of the authors provides a depth of perspective and boldness of innovative leadership to set the standards for future patient recruitment programs and practices. This book is a must-have for pharmaceutical, biotechnology and medical device industry professionals concerned with enrolling for domestic and multinational clinical studies and remaining on time and on budget.

'What gets measured gets fixed' and this is as true of the pharmaceutical industry as any other. The problem is that pharmaceutical businesses are complex. Drug research and development involves extended and expensive processes; defining appropriate metrics for these processes is not easy, yet ineffective or misguided metrics can be more damaging than none at all. David Zuckerman's Pharmaceutical Metrics is an extremely practical guide to selecting a system, selling it to top management, choosing and defining the right metrics for your system, communicating and displaying the results. And because metrics are about how to shape and develop your business, he explores how to deploy them organization-wide and make sure that they are driving business improvement. In order to reflect the needs of different types of pharmaceutical company the author uses four sample companies, throughout the book, to illustrate the principles for 'big pharma', 'micro pharma', a virtual development company and a CRO. This highly practical book provides a step-by-step guide to creating a state-of-the-art, strategy-driven metrics system for pharmaceutical R&D, supported by case studies of the techniques applied and tips for optimizing the system.

This volume, originally published in 1995, investigates the variation in rates of new venture inititations across manufacturing industries. Based on Austrain and other perspectives on market disequilibrium, the book proposes a model of new venture formation in dynamic markets. It focuses on the environmental factors which immpact rates of entrepreneurship in industries and argues that more dynamic industries will contain more profit opportunities and therefore exhibit a greater degree of entrepreneurship and new venture creation.

How to Create and Conduct Real-Life Reusable Case Studies with Industry
Employer Alliances and Projects
Written and Endorsed by Science and Business Professionals in the Research Triangle Park in North Carolina, USA.
Many students and university teachers are unfamiliar with the industry environment. Case studies developed in collaboration with working professionals can help students and professors bridge the gap between universities and industry.
This book provides guidance on how to approach industry professionals and create educational alliances. The strategy of establishing contact with industry employers and the process of developing and teaching case-studies are described. Among the case-studies are examples of how to identify biomarkers and new drugs simultaneously, prioritize and develop products in compliance with rules and regulations, commercialize products and protect and manage the intellectual property, optimize processes and technologies for manufacturing, and minimize human errors in production.

A US/Brazil trade conflict on the Brazilian protectionist electronics policy developed during 198589. In that period and under the threat of trade sanctions, a few changes were made in the Brazilian policy. Major consequences of the conflict were felt after its conclusion. It was one important political factor among the forces that pushed for the opening of the Brazilian electronics market in the early 1990s.

This major Handbook offers a comprehensive analysis of the key issues surrounding the rapid expansion of Latin America's manufacturing sector. It systematically examines the most important factors influencing the comparative advantages and the globalization of manufacturing industries in the region. The Handbook of Latin American Trade in Manufactures provides a detailed account of trade and investment policies, international technology transfers, macroeconomic stabilization and structural adjustment policies and industry-specific initiatives affecting the export competitiveness of Latin America's manufactures. The four major parts of the Handbook contain detailed assessments of regional and country-specific developments in manufacturing trade, and the statistical appendix provides essential information on the countries of the region. This Handbook will be welcomed by a wide range of economists in the fields of international trade and investment, industrial organization, development economics and Latin American Trade. It will also be of interest to business analysts and policymakers concerned with the formation of trade strategies.

This new edition provides an alternative overview of 18th-century British economy. Recent macroeconomic history has discounted many of the achievements of the Industrial Revolution, but this text dissects the characteristics and processes of industry in the 18th century. A male industrial revolution has been presented as the general experience, but new industries, notably in textiles and metal products, were primarily employers of women. This work gives these industries and their workforce due prominence. Technologies, work processes, labour forces and markets shifted in a variety of directions and forms to create a sector of dynamic new initiatives alongside stable and declining crafts. The key to the Industrial Revolution lies in the sources of technological creativity and the structures of industrial communities. The rise of the factory system was one result. This text reasserts the primacy of the industrial experience to Britain's economic history.

The contributing authors of Understanding the Japanese Food and Agrimarket discuss broad forces that affect markets in Japan and specific situations faced in marketing grain, livestock, and seafood products; fruits; vegetables; and wood products. Many of the contributors speak and read Japanese and have lived in Japan for extensive periods; they are able to give deep insights into how and why the Japanese consumption and distribution system behaves as it does. They draw on their expertise to fully explore various Japanese food and fiber markets. As they demystify the Japanese market, they illustrate for readers several systematic approaches to mastering the Japanese food and fiber markets.Readers will discover that effective long-term marketing strategies in Japan must be based on sound analytical information. The contributors provide such needed material with chapters on items as diverse as wine, grain products, beef, and fruits and vegetables. Some of the specific topics covered include: changes in Japanese food consumption Japanese food distribution system demand for beef products in Japan demand for vegetables and vegetable seeds Japanese wine market demand for bakery products new food products for the Japanese market developing trade relations in wood productsExecutives of commodity associations or firms exporting foods to Japan will find the general sections most interesting as well as chapters specific to their products. Teachers and students exploring exporting to the Japanese market will be intrigued by the various dimensions of the "multifaceted" nature and opportunities of the Japanese market.

Drug-related morbidity and mortality is rampant in contemporary industrial society, despite or perhaps because, government has assumed a critical role in the process by which drugs are developed and approved. Parrish asserts that, as a people, Americans need to understand how it is that government became the arbiter of pharmaceutical fact. The consequences of our failure to understand, he argues, may threaten individual choice and forestall the development of responsible therapeutics. Moreover, if current standards and control continues unabated, the next therapeutic reformation might well make possible the sanctioned commercial exploitation of patients. In Defining Drugs, Parrish argues that the federal government became arbiter of pharmaceutical fact because the professions of pharmacy and medicine, as well as the pharmaceutical industry, could enforce these definitions and standards only through police powers reserved to government. Parrish begins his provocative study by examining the development of the social system for regulating drug therapy in the United States. He reviews the standards that were negotiated, and the tensions of the period between Progressivism and the New Deal that gave cultural context and historical meaning to drug use in American society. Parrish describes issues related to the development of narcotics policy through education and legislation facilitated by James Beal and Edward Kremers, and documents the federal government's evolving role as arbiter of market tensions between pharmaceutical producers, government officials, and private citizens in professional groups, illustrating the influence of government in writing enforceable standards for pharmaceutical therapies. He shows how the expansion of political rights for practitioners and producers has shifted responsibility for therapeutic consequences from individual practitioners and patients to government. This timely and controversial volume is written for the scholar and the compassionate practitioner alike, and a general public concerned with pharmacy regulation in a free society.

This work covers in depth the new patterns of manufacturing and technology transfer that are emerging as Japanese companies seek to harness Asia's technological resources, and to utilise them to compete both regionally and globally.

Japanese manufacturing investment in the European Community has grown dramatically over the last twenty years. At first, instances of investment were few, concentrated in a small number of industrial sectors. But since the mid-1980's there has been a surge of investment in a much wider range of industries.
This volume details the growth of Japanese manufacturing investment in Europe in fourteen industrial sectors. The impact of Japanese competition and direct investment on European industries is considered in the context of the emergence of the three major trading blocs: the United States, Japan and the EC. Roger Strange concludes by making important policy recommendations, and arguing for the need for a new theoretical framework for assessing the political economy of foreign direct investment.

The inspection process is one of the most important steps in manufacturing industries because it safeguards high quality products and customer satisfaction. Manual inspection may not provide the desired accuracy. This book introduces and implements a new methodology and develops the supporting technologies for automated inspection planning based on Computer Aided Design (CAD) models. It also provides and implements an efficient link for automated operation based on Coordinate Measuring Machine (CMM). The link's output is a DMIS code programming file based on the inspection planning table that is executed on CMM.

The pharmaceutical industry has encountered major shifts in recent years, both within the industry, and in its external environment. The cost of healthcare rising due to an ageing population, the intensification of regulatory requirements and mergers within the industry have led to an increased need for restructuring, cost reduction and culture change projects. Project management is the key to addressing these needs, and also to effective drug development. Given the costs of development and the critical issue of 'time to market', project management techniques - appropriately used - are a key factor in bringing a drug to market. In this book, Laura Brown and Tony Grundy's pharmaceutical expertise and experience offers the reader a guide to the most relevant project management tools and techniques and how to rigorously apply them in the pharmaceutical industry. The authors cover the technical, strategic and human aspects of project management, including contingency planning, simulation techniques and different project options. Complete with decision-tree diagrams, checklists, exercises and a full glossary, Project Management for the Pharmaceutical Industry provides clinical research, drug development and quality assurance managers or directors with a one-stop reference for successfully managing pharmaceutical projects. The text has been revised for this edition and now includes some additional material on risk management.

The aim of this book is to provide statistical information on the various food industries. Each chapter covers one particular industry or a group of related industries and is organized in the same way. Statistical details are given on industry structure, the European Community, output, inputs, capital, labour, international transactions, stocks, consumption, prices, supplies and disposals, financial information, research and development, advertising and market research, official investigations and improvements and comments.

The phenomena of Japan emerging as one of the most competitive industrial nations in the twentieth century and the general shift of competitiveness to East Asia since the 1980s have been widely studied by many scholars from different fields of the social sciences. Drawing on sources from Japanese, Swiss, and American archives, the historical analysis of this book tackles a wide range of actors and sheds light on the various processes that enabled Japanese watch companies to transfer technology and expand commercially starting in the second half of the nineteenth century. By exploring the case of the watch industry, this book serves to establish a better understanding of the origins of the competitiveness of Japanese manufacturing and its evolution until its decline in the post-bubble economy (in the 1990s and 2000s).

By any standard, the pharmaceutical industry's history has been a successful one. In addition to its profits and shareholder dividends, it has been seen by investors as relatively low risk and, largely, counter-cyclical to stock market trends. However, that important contribution appears to be petering out, with significant global implications for employees, shareholders, governments and patients. This is not just caused by the economic crisis. Long before this, several distinct but related streams of evidence emerged that now point to the stalling of the pharmaceutical industry. The Future of Pharma examines the causes of the industry's potential decline and offers a convincing and rigorous analysis of the options open to it. What emerges is a landscape defined, on the one hand, by the changing marketplace of mass-market consumers, institutional healthcare systems and wealthy individuals; and on the other by the alternate sources of commercial value - innovative therapies; super-efficient processes, supply chains and operations; and closer customer relations and increasingly tailored health services. The challenges to the pharmaceutical industry now and in the medium and long-term are very significant. Brian Smith's highly readable research findings are a wake-up call and a first step forward for anyone concerned with the future of the industry; whether executive, customer, policymaker or investor.